Pink Cleats to Show Support Of Breast cancer Awareness - New York Times
Market Wire (press release)Pink Cleats to Show Support Of Breast cancer AwarenessNew York TimesAs part of the NFL's support of Breast cancer Awareness Month in October, players will be wearing hot pink gear starting Sunday: gloves, ...Breast cancer deaths continue declineLos Angeles TimesTanya Snyder Steps Up to Lead Breast cancer FightWashington PostSocial isolation 'worsens cancer'BBC NewsAtlanta Journal Constitution�-Chicago Sun-Times�-Los Angeles Timesall 337 news articles��

Blog Content

FDA approves pralatrexate for peripheral T-cell lymphoma - HemOncToday
The Money TimesFDA approves pralatrexate for peripheral T-cell lymphomaHemOncTodayLast week, the FDA announced accelerated approval of pralatrexate, the first drug approved for peripheral T-cell lymphoma. The approval comes just weeks ...Folotyn Gets OK for Rare lymphoma TreatmentAbout - News %26 Issues (blog)all 11 news articles��

Blog Content

Allos says FDA clears lymphoma drug Folotyn - Forbes
TopNews United StatesAllos says FDA clears lymphoma drug FolotynForbesThe approval was sped up because peripheral T-cell lymphoma is an uncommon disease and no other treatments are available, the FDA said. ...FDA OKs Allos' lymphoma Drug Folotyn; Shares UpWall Street JournalFolotyn Approved for Aggressive Type of Non-Hodgkin's lymphomaAtlanta Journal ConstitutionFDA Approves Allos lymphoma Drug: BioBuzzTheStreet.comReuters�-RTT News�-BioWorld Onlineall 77 news articles��

Blog Marketing

Allos says FDA clears lymphoma drug Folotyn - Forbes
Allos says FDA clears lymphoma drug FolotynForbesThe approval was sped up because peripheral T-cell lymphoma is an uncommon disease and no other treatments are available, the FDA said. ...FDA OKs Allos' lymphoma Drug Folotyn; Shares UpWall Street JournalFolotyn Approved for Aggressive Type of Non-Hodgkin's lymphomaAtlanta Journal ConstitutionFDA Approves Allos lymphoma Drug: BioBuzzTheStreet.comReuters�-RTT News�-BioWorld Onlineall 67 news articles��

Blog Marketing

Amgen Reports Progress With Colorectal-cancer Drug - Wall Street Journal
Amgen Reports Progress With Colorectal-cancer DrugWall Street Journal... reported progress in a Phase III trial of Vectibix combined with the chemotherapy Folfox as a first-line treatment for metastatic colorectal cancer. ...cancer drug Erbitux extends life in one studyReutersAmgen Reports Positive Colon cancer Drug ResultsMarketNewsVideo.comMerck KGaA's Erbitux Drug Helps Colon cancer PatientsBloombergTrading Markets (press release)�-Wall Street Journal�-Wall Street Journalall 107 news articles��

Blog Marketing

Study Shows Roche's MabThera Helps Follicular lymphoma Patients - Wall Street Journal
Sawf NewsStudy Shows Roche's MabThera Helps Follicular lymphoma PatientsWall Street Journal"The potential new indication in follicular lymphoma would be a nice-to-have, but the impact on sales would be limited as the drug is already used in ...Roche's Rituxan stops lymphoma worsening-studyReutersGenentech: Rituxan Helps Low-Grade lymphoma PatientsNASDAQRituxan tests positive in Phase III trialFiercePharmaPharmacy Europe�-Forbes�-Reutersall 36 news articles��

Blog Content